- FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use CNBC
- F.D.A. Approves Ozempic to Treat Kidney Disease The New York Times
- US FDA Approves Novo Nordisk’s Diabetes Drug to Reduce Risk of Worsening Kidney Disease U.S. News & World Report
- Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment The Wall Street Journal
- Novo’s Ozempic Notches Approval for Kidney Disease, Widening Use Bloomberg